Leukotriene D4 251D-646 ¹⁷]heptadec-11-ene-3

¹⁷]heptadec-11-ene-3

56 mg/mL (12

Smiles: C[C@@H]1O[C@@H](O[C@H]2[C@H](OC(=O)[C@]3(C)CCC[C@@]4(C)[C@@H]5CC[C@@]6(C[C@]5(CC6=C)CC[C@@H]43)O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@H]3O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H](O)[C@H]1O

Ribostamycin is as an intermediate in the biosynthesis of neomycin

1 μM) inhibits EGFR potently and irreversibly

Leukotriene D4 251D-646 ¹⁷]heptadec-11-ene-3Leukotriene D4 is one of the constituents of slow reacting substance of anaphylaxis (SRS A) produced by the metabolism of LTC4 by glutamyl transpeptidase. Leukotriene D4 is the first cysteinyl leukotriene metabolite of LTC4. Leukotriene D4 induced bronchoconstriction and enhanced vascular permeability contribute to the pathogenesis of asthma and acute hypersensitivity. Product information CAS Number: 73836 78 9 Molecular Weight: 496. 66 Formula: